• Activity INFORMATION

  Overview

  This educational program is specifically designed to bridge the knowledge gap among pharmacists and pharmacy technicians regarding human immunodeficiency (HIV) preexposure prophylaxis (PrEP), a critical area in healthcare that demands informed and proactive involvement from these professionals. The program aims to enhance understanding of the latest guideline recommendations for HIV PrEP, ensuring participants are well-versed in the most current standards of care. It delves into the safety and efficacy data of FDA-approved agents for HIV PrEP, providing the necessary scientific background to support clinical decisions. Importantly, the program also focuses on the pivotal roles pharmacists and pharmacy technicians play in managing high-risk patients. This includes addressing barriers to care, expanding awareness, and making informed clinical recommendations. Through comprehensive patient counseling and effective communication strategies, participants will be equipped to make a significant impact in the prevention of HIV, ultimately contributing to better patient outcomes and public health advancements. This educational activity is crucial in addressing the existing gaps in clinical practice and empowering pharmacy professionals to take a proactive role in HIV prevention.
  

  Handouts

  • Homestudy PDF :   24105H02.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Interpret safety and efficacy data regarding FDA-approved therapies for HIV PrEP

  Recall clinical guideline recommendations surrounding human immunodeficiency (HIV) pre-exposure prophylaxis (PrEP)

  Identify the various responsibilities and roles of pharmacists in the management of HIV PrEP, focusing on their part in detecting and overcoming barriers, increasing knowledge about PrEP therapies, providing clinical advice, and educating patients about the effective and safe administration of PrEP therapies

  Nurse

  Identify the various responsibilities and roles of pharmacists in the management of HIV PrEP, focusing on their part in detecting and overcoming barriers, increasing knowledge about PrEP therapies, providing clinical advice, and educating patients about the effective and safe administration of PrEP therapies

  Recall clinical guideline recommendations surrounding human immunodeficiency (HIV) pre-exposure prophylaxis (PrEP)

  Interpret safety and efficacy data regarding FDA-approved therapies for HIV PrEP

  Nurse Practitioner

  Interpret safety and efficacy data regarding FDA-approved therapies for HIV PrEP

  Recall clinical guideline recommendations surrounding human immunodeficiency (HIV) pre-exposure prophylaxis (PrEP)

  Identify the various responsibilities and roles of pharmacists in the management of HIV PrEP, focusing on their part in detecting and overcoming barriers, increasing knowledge about PrEP therapies, providing clinical advice, and educating patients about the effective and safe administration of PrEP therapies

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1193612

  Universal Activity Number

  Pharmacist 0798-0000-24-105-H02-P
  Nurse 0798-0000-24-105-H02-N
  Nurse Practitioner 0798-0000-24-105-H02
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Lance  Azzo, PharmD Freelance Medical Writer

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).